These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3551350)

  • 1. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial].
    Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H
    Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
    Eitner L; Wettengel R; Schnitker J
    Prax Klin Pneumol; 1983 Jun; 37(6):236-42. PubMed ID: 6889277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
    Geisler LS; Thiel H; Förster OB; Rohner HG
    Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].
    Katz G; Kewitz G; Vozeh S; Follath F
    Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind trial of oral aminophylline (Phyllocontin Continus tablets) in airflow obstruction: preliminary communication.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    J Int Med Res; 1979; 7 Suppl 1():47-51. PubMed ID: 374164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibilities for optimizing therapy with theophylline preparations. Clinical effectiveness and side effects of microcrystalline theophylline].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):11-7. PubMed ID: 6426180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with a retard theophylline preparation].
    Keller A; Bömches B; Kandt D
    Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
    Dal Negro R; Turco P; Pomari C; Monici-Preti P
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release oral aminophylline in patients with airflow obstruction.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    Thorax; 1981 Apr; 36(4):303-7. PubMed ID: 7025336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.